These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28263138)

  • 41. [Clinical Study of Percutaneous Radiofrequency Ablation for Small Renal Tumor].
    Fujiwara R; Yamashita H; Imoto K; Yamazaki M; Kim CJ
    Hinyokika Kiyo; 2016 Oct; 62(10):509-514. PubMed ID: 27919123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thermal versus impedance-based ablation of renal cell carcinoma: a meta-analysis.
    Modabber M; Martin J; Athreya S
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):176-85. PubMed ID: 24091755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiofrequency ablation used to treat select renal and adrenal tumors.
    Zuboy J
    Curr Treat Options Oncol; 2000 Jun; 1(2):93-4. PubMed ID: 12061373
    [No Abstract]   [Full Text] [Related]  

  • 44. C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma.
    Duan XH; Li YS; Han XW; Wang YL; Jiao DC; Li TF; Chen PF; Fang Y
    Clin Radiol; 2016 Jan; 71(1):79-85. PubMed ID: 26602936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma.
    Zagoria RJ; Pettus JA; Rogers M; Werle DM; Childs D; Leyendecker JR
    Urology; 2011 Jun; 77(6):1393-7. PubMed ID: 21492910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RFA of renal cell carcinoma in a solitary kidney.
    Hoffmann RT; Jakobs TF; Trumm C; Helmberger TK; Reiser MF
    Abdom Imaging; 2008; 33(2):230-6. PubMed ID: 17401600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.
    Varkarakis IM; Allaf ME; Inagaki T; Bhayani SB; Chan DY; Su LM; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2005 Aug; 174(2):456-60; discussion 460. PubMed ID: 16006864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency ablation of synchronous bilateral renal cell carcinoma.
    Zhang S; Zhao X; Ji C; Liu G; Li X; Zhang G; Gan W; Guo H
    Int J Urol; 2012 Mar; 19(3):241-7. PubMed ID: 22129157
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immediate and long-term CT appearances following radiofrequency ablation of renal tumours.
    Rutherford EE; Cast JE; Breen DJ
    Clin Radiol; 2008 Feb; 63(2):220-30. PubMed ID: 18194700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pro percutaneous-ablative tumor therapy].
    Brehmer B; Jakse G
    Aktuelle Urol; 2007 Mar; 38(2):101-3. PubMed ID: 17438641
    [No Abstract]   [Full Text] [Related]  

  • 53. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.
    Permpongkosol S; Link RE; Solomon SB; Kavoussi LR
    J Urol; 2006 Aug; 176(2):463-7; discussion 467. PubMed ID: 16813865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiofrequency ablation: an alternative treatment method of renal cell carcinoma.
    Lui KW; Gervais DA; Mueller PR
    Chang Gung Med J; 2004 Aug; 27(8):618-23. PubMed ID: 15553610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique.
    Wah TM; Koenig P; Irving HC; Gervais DA; Mueller PR
    J Vasc Interv Radiol; 2005 Nov; 16(11):1551-5. PubMed ID: 16319166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiofrequency ablation of renal cell carcinoma.
    Schiller JD; Gervais DA; Mueller PR
    Abdom Imaging; 2005; 30(4):442-50. PubMed ID: 16132440
    [No Abstract]   [Full Text] [Related]  

  • 57. Editorial comment for Chen et al.
    Caddedu JA
    J Endourol; 2013 Jun; 27(6):704. PubMed ID: 23441601
    [No Abstract]   [Full Text] [Related]  

  • 58. Sonographically guided percutaneous radio frequency ablation of a renal cell carcinoma in a transplanted kidney.
    Charboneau JW; O'Loughlin MT; Milliner DS; Engen DE
    J Ultrasound Med; 2002 Nov; 21(11):1299-302. PubMed ID: 12418770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work.
    Watkins TW; Parkinson R
    Australas Radiol; 2007 Oct; 51(5):412-9. PubMed ID: 17803791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of percutaneous radiofrequency ablation in pulmonary metastases from renal cell carcinoma.
    Shu Yan Huo A; Lawson Morris D; King J; Glenn D
    Ann Surg Oncol; 2009 Nov; 16(11):3169-75. PubMed ID: 19680727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.